Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 6:10.1097/WNO.0000000000002388.
doi: 10.1097/WNO.0000000000002388. Online ahead of print.

Evaluation of Racial, Ethnic, and Socioeconomic Disparities in Idiopathic Intracranial Hypertension

Affiliations

Evaluation of Racial, Ethnic, and Socioeconomic Disparities in Idiopathic Intracranial Hypertension

Jane J Huang et al. J Neuroophthalmol. .

Abstract

Background: Idiopathic intracranial hypertension (IIH) disproportionately affects young, Black, female patients. However, there are limited data characterizing baseline and outcome features of IIH across racial and socioeconomic groups. This study aimed to compare presenting features, initial MRI findings, and visual outcomes of IIH from different racial, ethnic, and insured groups.

Methods: We conducted a retrospective chart review of patients with IIH seen at an academic quaternary care center between July 1, 2013, and September 30, 2023. Patient characteristics collected were self-reported race and ethnicity, insurance status, age, and sex. Clinical features included lumbar puncture (LP) opening pressure; body mass index (BMI); visual acuity (VA), visual field mean deviation, and average retinal nerve fiber layer (RNFL) thickness at presentation and follow up; MRI findings; presence of symptoms (headaches, diplopia, transient visual obscurations, pulsatile tinnitus), treatment(s); and adherence to follow-up recommendations. Patients were excluded if they were already treated for IIH before initial presentation or if diagnostic data were incomplete. Linear, mixed effect, and logistic regression models were used to evaluate differences between racial, ethnic, and insurance status groups. Statistical significance was set at P < 0.05.

Results: Our study included 241 patients. There were no statistically significant differences in BMI, presence of symptoms of high intracranial pressure, visual function, or RNFL thickness at initial evaluation between groups stratified by race, ethnicity, and insurance status. Black patients were more likely to have Medicaid coverage, whereas White patients were more likely to have private insurance (Medicaid: 38% Black vs 14% White; private: 47% Black vs 67% White, P < 0.001). Black patients were more likely to have posterior globe flattening on initial MRI, and patients with Medicare coverage had significantly worse VA outcomes than those with Medicaid coverage. There were no other statistically significant differences in presenting features, clinical outcomes, or adherence to follow-up recommendations across patient subgroups.

Conclusions: There were no statistically significant differences in presenting symptoms of IIH, BMI, LP opening pressure, or adherence to follow-up based on race, ethnicity, or insurance status. Patients with Medicare coverage had worse VA outcomes than those with Medicaid coverage. Otherwise, visual outcomes were similar across groups.

PubMed Disclaimer

Conflict of interest statement

A. D. Henderson has participated in Advisory Boards for Horizon Therapeutics/Amgen and Catalyst Pharmaceuticals, and she participates in sponsored research for Argenx. These disclosures are not related to the content of this manuscript. The remaining authors report no conflicts of interest.

Similar articles

References

    1. Friedman D, Liu G, Digre K. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81(13):1159–1165. - PubMed
    1. Cho KH, Baek SH, Kim SH, Kim BS, Sohn JH, Chu MK, Kang MK, Mo HJ, Lee SH, Park HK, Cho S, Oh SY, Seo JG, Lee W, Lee JY, Lee MJ, Cho SJ. Clinical profile and treatment outcomes of idiopathic intracranial hypertension: a multicenter study from Korea. J Headache Pain. 2024;25(1):106. doi: 10.1186/s10194-024-01794-3 - DOI - PMC - PubMed
    1. Subramanian PS. Novel Approaches to the Treatment of Idiopathic Intracranial Hypertension. Curr Neurol Neurosci Rep. 2024;24(8):265–272. doi: 10.1007/s11910-024-01347-w - DOI - PubMed
    1. Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, McDermott MP. The Idiopathic Intracranial Hypertension Treatment Trial: Clinical Profile at Baseline. JAMA Neurol. 2014;71(6):693. doi: 10.1001/jamaneurol.2014.133 - DOI - PMC - PubMed
    1. Shaia JK, Sharma N, Kumar M, Chu J, Maatouk C, Talcott K, Singh R, Cohen DA. Changes in Prevalence of Idiopathic Intracranial Hypertension in the United States Between 2015 and 2022, Stratified by Sex, Race, and Ethnicity. Neurology. 2024;102(3):e208036. doi: 10.1212/WNL.0000000000208036 - DOI - PMC - PubMed

LinkOut - more resources